Cage Pharma

About:

Cage Pharma is a pre-clinical biopharmaceutical company that develops new drugs targeting the metabolism of tumors.

Website: http://cagephar.ma/

Description:

Cage Pharma is a pre-clinical biopharmaceutical company that develops new drugs targeting the metabolism of tumors. The company's encapsulated anti-cancer agent is developed using a novel formulation of a particular halopyruvate called 3-bromopyruvate to target cancer by directly attacking one of its key hallmarks, tumor glycolysis, enabling medical practitioners to achieve efficacy as an anti-cancer agent with a controlled and mild toxicity profile. Cage Pharma was founded in 2017 and is headquartered in Baltimore, Maryland.

Total Funding Amount:

$967000

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Baltimore, Maryland, United States

Founded Date:

2017-01-01

Contact Email:

info(AT)cagephar.ma

Founders:

Jean-Francois Geschwind

Number of Employees:

1-10

Last Funding Date:

2024-05-31

IPO Status:

Private

Industries:

© 2025 bioDAO.ai